Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial) - Concepedia

Concepedia

Publication | Closed Access

Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)

345

Citations

21

References

2011

Year

Harold Bays, Christie M. Ballantyne, John J.P. Kastelein, Jonathan L. Isaacsohn, Rene A. Braeckman, Paresh N. Soni

The American Journal of Cardiology

Metabolic SyndromeLipid DisorderCardiovascular DiseaseMedicineDiabetesPharmacotherapyPharmacologyAtherosclerosisDyslipidemia12-Week Study

References

	Year	Citations

Page 1